LX101
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LX101, covering 2025-06-29 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations [Phase 1]